Development and Validation Study of the Prognostic Impact of Deep Learning-Determined Myxoid Stroma After Neoadjuvant Chemotherapy in Patients with Esophageal Squamous Cell Carcinoma.

Keita KouzuHironori TsujimotoYu ImamuraYoshiki KajiwaraInes P NearchouTakahiro EinamaManabu TakamatsuIkumi HaraguchiTakanori WatanabeHiroyuki HoriguchiYoji KishiHitoshi TsudaMasayuki WatanabeHideki Ueno

Published in: Annals of surgical oncology (2024)

AI-determined myxoid stroma may be a novel and useful prognostic factor for patients with pathological stage II or III ESCC after NAC.

Keyphrases

neoadjuvant chemotherapy
prognostic factors
deep learning
locally advanced
lymph node
artificial intelligence
sentinel lymph node
transcription factor
squamous cell carcinoma
machine learning
rectal cancer
early stage